The aim of this trial is to evaluate if P-15L bone graft (investigational device) is not inferior in effectiveness and safety to local autologous bone (and allograft where necessary) as an extender (control device) when applied in instrumented transforaminal lumbar interbody fusion (TLIF) in subjects with degenerative disc disease (DDD). In addition to the general overall objective, a sub-group analysis will be performed on the high-risk subject population (tobacco use, obesity, diabetes), as previous studies have shown negative effects of smoking, obesity and diabetes on fusion and bone healing, increased peri/postoperative complications, and lower patient-reported outcome scores.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
290
The investigational group will be treated with P-15L in an instrumented TLIF
The active control group will be treated local autologous bone in an instrumented TLIF
The University of Alabama at Birmingham
Birmingham, Alabama, United States
Glendale Adventist Medical Center
Glendale, California, United States
Keck School of Medicine USC
Los Angeles, California, United States
UC Irvine Medical Center
Orange, California, United States
UC Davis Spine Center
Sacramento, California, United States
Secondary surgical intervention
No index level secondary surgical intervention
Time frame: 72 Months
Fusion
Achievement of fusion (Fusion is defined as evidence of bridging trabecular bone between the vertebral bodies by CT scan)
Time frame: 72 Months
Oswestry Disability Index (ODI)
At least 15-point improvement in Oswestry Disability Index (ODI)
Time frame: 72 Months
Neurological deficit
No new or worsening, persistent neurological deficit
Time frame: 72 Months
No serious device-related adverse event
No serious device-related adverse event
Time frame: 72 Months
Time to Fusion
The distribution of visits (month 6, 12, or 24) at which fusion is confirmed is the same for the investigational and control devices.
Time frame: 24 months
VAS pain scores
Pain at back and pain at legs will be measured by a 100-point Visual Analog Scale (VAS)
Time frame: 72 months
Physical Function and Mental Health Composite Scores
SF-12 and changes over time
Time frame: 72 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Cedars-Sinai
West Hollywood, California, United States
Center for Spine and Orthopedics
Thornton, Colorado, United States
UConn Health
Farmington, Connecticut, United States
St. Francis Hospital and Medical Center
Hartford, Connecticut, United States
University of South Florida
Tampa, Florida, United States
...and 24 more locations